Cargando…
Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest
Objectives To evaluate the efficacy of oestradiol valerate/dienogest (E(2)V/DNG) for the treatment of heavy and/or prolonged menstrual bleeding without organic pathology based on the analysis of data from two identically designed double-blind, randomised studies. Methods Women aged ≥ 18 years with h...
Autores principales: | Fraser, Ian S, Parked, Susanne, Mellinger, Uwe, Machlitt, Andrea, Serrani, Marco, Jensen, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Century Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154543/ https://www.ncbi.nlm.nih.gov/pubmed/21774563 http://dx.doi.org/10.3109/13625187.2011.591456 |
Ejemplares similares
-
Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
por: Rafie, Sally, et al.
Publicado: (2013) -
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
por: Bitzer, Johannes, et al.
Publicado: (2011) -
Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding
por: Wasiak, Radoslaw, et al.
Publicado: (2012) -
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel
por: Klipping, Christine, et al.
Publicado: (2012) -
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
por: Nappi, Rossella E, et al.
Publicado: (2014)